Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 4 II, 1998, Pages 699-700

  Duplantier, John E ^a   Nelson Jr , Robert P ^a   Morelli, Anthony R ^b   Good, Robert A ^a   Kornfeld, Stephen J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Diagnostic Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PREDNISOLONE; PREDNISONE; SALBUTAMOL; TRIAMCINOLONE;

ADOLESCENT; ADRENAL SUPPRESSION; ARTICLE; ASTHMA; CASE REPORT; ENDOCRINE DISEASE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; STEROID THERAPY;

EID: 0031768757     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70292-1     Document Type: Article

References (5)

1. Hollman GA, Allen DB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 1988;81:452-5.
2. Thorsson L, Dahlström K, Edsbäcker S, Källén A, Paulson J, Wirén JE. Pharmacokinetics and systemic effects of inhaled fluticasone propionate. Br J Clin Pharmacol 1997;43:155-61.
3. Ayres JG, Bateman ED, Lundbäck B, Harris TAJ. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 1995;8:579-86.
4. Tan KS, Grove A, Cargill RI, McFarlane LC, Lipworth BJ. Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte β-2 adrenoreceptor function in asthmatic patients. Chest 1996;109:343-7.
5. Todd G, Dunlop K, McNaboe J, Ryan ME, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996;348:27-9.